NO20051287L - Aerosolformulering for inhalasjon som inneholder et anticholinergisk middel - Google Patents

Aerosolformulering for inhalasjon som inneholder et anticholinergisk middel

Info

Publication number
NO20051287L
NO20051287L NO20051287A NO20051287A NO20051287L NO 20051287 L NO20051287 L NO 20051287L NO 20051287 A NO20051287 A NO 20051287A NO 20051287 A NO20051287 A NO 20051287A NO 20051287 L NO20051287 L NO 20051287L
Authority
NO
Norway
Prior art keywords
inhalation
aerosol formulation
anticholinergic agent
aza
oxa
Prior art date
Application number
NO20051287A
Other languages
English (en)
Norwegian (no)
Other versions
NO20051287D0 (no
Inventor
Friedrich Schmidt
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31979448&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20051287(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10237232A external-priority patent/DE10237232A1/de
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20051287D0 publication Critical patent/NO20051287D0/no
Publication of NO20051287L publication Critical patent/NO20051287L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20051287A 2002-08-14 2005-03-11 Aerosolformulering for inhalasjon som inneholder et anticholinergisk middel NO20051287L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10237232A DE10237232A1 (de) 2002-08-14 2002-08-14 Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE10240257 2002-08-31
PCT/EP2003/008221 WO2004022052A1 (fr) 2002-08-14 2003-07-25 Formulation aerosol pour l'inhalation contenant un anticholinergique

Publications (2)

Publication Number Publication Date
NO20051287D0 NO20051287D0 (no) 2005-03-11
NO20051287L true NO20051287L (no) 2005-03-11

Family

ID=31979448

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051287A NO20051287L (no) 2002-08-14 2005-03-11 Aerosolformulering for inhalasjon som inneholder et anticholinergisk middel

Country Status (31)

Country Link
EP (2) EP1530464B1 (fr)
JP (1) JP4602767B2 (fr)
KR (1) KR101060972B1 (fr)
CN (1) CN1674887A (fr)
AT (1) ATE400265T1 (fr)
AU (1) AU2003298473B9 (fr)
BR (1) BR0313457A (fr)
CA (1) CA2495275C (fr)
CY (1) CY1108776T1 (fr)
DE (1) DE50310117D1 (fr)
DK (1) DK1530464T3 (fr)
EA (1) EA009936B1 (fr)
EC (1) ECSP055600A (fr)
ES (1) ES2305479T3 (fr)
HR (1) HRP20050132A2 (fr)
IL (1) IL166814A (fr)
MX (1) MXPA05001595A (fr)
MY (1) MY142579A (fr)
NO (1) NO20051287L (fr)
NZ (1) NZ538743A (fr)
PE (1) PE20040372A1 (fr)
PL (1) PL375511A1 (fr)
PT (1) PT1530464E (fr)
RS (1) RS51396B (fr)
SA (1) SA03240265B1 (fr)
SI (1) SI1530464T1 (fr)
TW (1) TWI317279B (fr)
UA (1) UA81775C2 (fr)
UY (1) UY27938A1 (fr)
WO (1) WO2004022052A1 (fr)
ZA (1) ZA200410325B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004038885A1 (de) * 2004-08-10 2006-02-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005001297A1 (de) * 2005-01-12 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055958A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055960A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055957A1 (de) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055963A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
EP2414560B1 (fr) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Procédé de revêtement d'une surface d'un composant
WO2010133294A2 (fr) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapteur, dispositif d'inhalation et nébuliseur
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
CN102686260B (zh) 2009-11-25 2014-10-01 贝林格尔.英格海姆国际有限公司 喷雾器
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (fr) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Appareil médical pourvu d'un récipient
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
US9877486B2 (en) 2014-01-31 2018-01-30 AgBiome, Inc. Methods of growing plants using modified biological control agents
PT3099172T (pt) 2014-01-31 2021-11-08 Agbiome Inc Agentes modificados de controlo biológico e seus usos
EP3139979B1 (fr) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unité, nébuliseur et procédé
UA121114C2 (uk) 2014-05-07 2020-04-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх Небулайзер, індикаторний пристрій і контейнер
ES2874029T3 (es) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizador

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
ME00220B (me) * 2000-05-22 2010-10-10 Chiesi Farm Spa Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10063957A1 (de) * 2000-12-20 2002-06-27 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Dopamin-Agonisten
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern

Also Published As

Publication number Publication date
CA2495275C (fr) 2012-04-17
CY1108776T1 (el) 2014-04-09
ECSP055600A (es) 2005-04-18
DE50310117D1 (de) 2008-08-21
PL375511A1 (en) 2005-11-28
TWI317279B (en) 2009-11-21
NO20051287D0 (no) 2005-03-11
KR20050049478A (ko) 2005-05-25
MXPA05001595A (es) 2005-04-25
AU2003298473B2 (en) 2009-04-23
JP2006506345A (ja) 2006-02-23
EP1530464B1 (fr) 2008-07-09
AU2003298473B9 (en) 2011-06-09
CN1674887A (zh) 2005-09-28
TW200406213A (en) 2004-05-01
HRP20050132A2 (en) 2006-05-31
AU2003298473A1 (en) 2004-03-29
RS20050074A (en) 2007-09-21
UA81775C2 (uk) 2008-02-11
DK1530464T3 (da) 2008-09-08
ATE400265T1 (de) 2008-07-15
PT1530464E (pt) 2008-08-28
EA200500292A1 (ru) 2005-10-27
CA2495275A1 (fr) 2004-03-18
WO2004022052A1 (fr) 2004-03-18
EA009936B1 (ru) 2008-04-28
ES2305479T3 (es) 2008-11-01
PE20040372A1 (es) 2004-08-03
MY142579A (en) 2010-12-15
KR101060972B1 (ko) 2011-09-01
IL166814A (en) 2010-11-30
RS51396B (en) 2011-02-28
SA03240265B1 (ar) 2009-11-10
EP1530464A1 (fr) 2005-05-18
NZ538743A (en) 2006-05-26
SI1530464T1 (sl) 2008-12-31
JP4602767B2 (ja) 2010-12-22
UY27938A1 (es) 2004-03-31
EP1908468A1 (fr) 2008-04-09
IL166814A0 (en) 2006-01-15
ZA200410325B (en) 2006-10-25
BR0313457A (pt) 2005-06-21

Similar Documents

Publication Publication Date Title
NO20051287D0 (no) Aerosolformulering for inhalasjon som inneholder et anticholinergisk middel
HRP20080140T3 (en) Aerosol formulation for inhalation, containing an anticholinergic agent
CO5540380A2 (es) Medicamentos inhalativos que contienen un nuevo anticolinergico en combinacion con corticosteroides y betamimeticos
RU2361593C3 (ru) Комбинация азеластина и стероидов
WO2007060104A3 (fr) Formulation d'aerosol destinee a l'inhalation contenant un agent anticholinergique
WO2007060108A3 (fr) Formulation d'aerosol destinee a l'inhalation contenant un agent anticholinergique
AR039404A1 (es) Combinaciones de medicamentos que contienen compuestos heterociclicos y un agente anticolinergico. aerosol para su inhalacion
JP2006506345A5 (fr)
SE0002476D0 (sv) New compounds
EP2253312A3 (fr) Utilisation d'osmolytes obtenus à partir de bacteries extremophiles pour produire des médicaments inhalables pour la prophylaxie et le traitment de maladies pulmonaires et cardiovasculaires et un dispositif d'inhalation contenant des osmolytes comme composants actifs
NO337768B1 (no) Væskeformig, farmasøytisk preparat av piperazinderivater, og minst ett konserveringsmiddel av parahydroksybenzoatestere
ZA200409676B (en) Novel drug compositions based on novel anticholinergics and inhibitors of EGFR-kinase
AR040864A1 (es) Formulacion aerosol para inhalacion, que contiene un agente anticolinergico
TH65183A (th) สูตรผสมแอโรซอลสำหรับยาสูดซึ่งประกอบรวมด้วยแอนติโคลิเนอร์จิก

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application